David Kessler is out of the running for nomination as FDA commissioner, leaving Janet Woodcock and Joshua Sharfstein as front-runners to lead the regulatory agency according to reports from Bloomberg and Biocentury. The latter notes that while the list of candidates had narrowed to Kessler and Sharfstein the delay in naming a candidate for the position could be a sign that other names are being considered. Janet Woodcock, longtime director of the Center for Drug Evaluation and Research (CDER) and a 30-year veteran of the FDA, is expected to be named acting FDA commissioner next week according to sources who spoke on condition of anonymity.
Learn More